Management of submacular haemorrhage in age-related macular degeneration with intravitreal tenectepl...
Management of submacular haemorrhage in age-related macular degeneration with intravitreal tenecteplase
About this item
Full title
Author / Creator
Publisher
BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
Background and aims We have previously reported that the thrombolytic tenecteplase (TNK) is able to penetrate the retina following an intravitreal injection of 50 μg with no evidence of retinal toxicity. 1-3 The purpose of this report, which is the first in humans, is to assess its efficacy and safety in the management of patients with submacular...
Alternative Titles
Full title
Management of submacular haemorrhage in age-related macular degeneration with intravitreal tenecteplase
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_733671649
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733671649
Other Identifiers
ISSN
0007-1161
E-ISSN
1468-2079
DOI
10.1136/bjo.2009.158170
